Table 4.
Laboratory results of COVID-19.
| Moderate n = 140 | Severe n = 123 |
Critically severe nn = 41 |
P-valuea | P-valueb | P-valuec | |
|---|---|---|---|---|---|---|
| Age, mean (SD), y | 55.9 (14.4) | 63.8 (13.9) | 65.2 (12.7) | 0.06 | 0.05 | 0.06 |
| Female | 85 | 65 | 16 | 0.25 | 0.01 | 0.2 |
| Male | 55 | 58 | 25 | |||
| WBC, x109/L | 5.72 (2.03) | 6.47 (2.8) | 8.97 (4.89) | 0.03 | <0.01 | <0.01 |
| Lymphocyte, x109/L | 1.44 (0.6) | 1.05 (0.8) | 0.68 (0.44) | <0.01 | <0.01 | <0.01 |
| Lymphocyte ratio, % | 26.59 (10.17) | 17.23 (8.64) | 10.55 (11.44) | <0.01 | <0.01 | <0.01 |
| Neutrophil, x109/L | 3.77 (1.82) | 5.02 (2.7) | 7.86 (4.82) | <0.01 | <0.01 | <0.01 |
| Platelet, x109/L | 223 (76) | 193 (85) | 173 (91) | <0.01 | <0.01 | 0.16 |
| CRP, mg/L | 16 (30) | 46.2 (56.5) | 114.8 (87.94) | <0.01 | <0.01 | <0.01 |
| NLR, % | 3.1 (2.41) | 6.92 (6.3) | 19.47 (24.35) | <0.01 | <0.01 | <0.01 |
| PLR, % | 181 (97) | 234 (169) | 346 (243) | <0.01 | <0.01 | <0.01 |
| Albumin, g/L | 35.73 (3.96) | 33.68 (4.81) | 29.48 (3.14) | 0.002 | <0.001 | 0.553 |
| Troponin-I, ug/L | 0.058 (0.17) | 0.07 (0.11) | 0.77 (1.35) | 0.921 | <0.001 | 0.475 |
| Creatinine, umol/L | 51.31 (36.62) | 226.39 (384.2) | 249.2 (348) | <0.001 | <0.001 | 0.317 |
| BUN, mmol/L | 5.48 (2.9) | 8.17 (7.12) | 11.32 (8.29) | <0.001 | <0.001 | 0.834 |
P-valuea indicates differences between moderate and severe group; P-valueb indicates differences between moderate and critically severe group; P-valuec indicates differences between severe and critically severe group; P < 0.05 was considered statistically significant.